Stocks · Healthcare · Biotechnology
MaxCyte, Inc. MXCT
$1.07 -1.83% Close, Oct 2, 2026 · NASDAQ · Market cap $114.6M
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -111.6% from -149.6% a year earlier.
- Over the past year the stock returned -33.1%, behind the S&P 500 by 48.2 percentage points.
- Revenue over the last four quarters was $31.1M, down 13.2% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 18%
- Revenue growth, 3-year CAGRBottom 12%
- Revenue growth accelerationTop 36%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 50%
- Gross marginTop 32%
- Operating marginBottom 28%
- Accruals (lower is better)Top 49%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 23%
- Free-cash-flow yieldBottom 24%
- EBITDA / enterprise valueBottom 23%
- Sales / enterprise valueTop 46%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 22%
- 6-month returnTop 23%
- 1-year return vs S&P 500Bottom 20%
- Distance from 52-week highBottom 37%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 21%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyBottom 34%
- Upside to consensus price targetTop 5%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 42%
- Maximum drawdown, 3 yearsBottom 20%
- Beta vs S&P 500 (lower is better)Bottom 49%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -14.3% | -13.2% | ↑ |
| Gross margin | 79.8% | 79.4% | ↓ |
| Operating margin | -149.6% | -111.6% | ↑ |
| FCF margin | -107.0% | -76.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -13.2% | -14.3% | ↑ | Bottom 18% |
| Gross margin | 79.4% | 79.8% | ↓ | Top 32% |
| Operating margin | -111.6% | -149.6% | ↑ | Bottom 28% |
| Net margin | -114.8% | -125.2% | ↑ | — |
| Free-cash-flow margin | -76.6% | -107.0% | ↑ | — |
| Return on invested capital | -19.7% | — | Top 50% | |
| Revenue growth, 3-year CAGR | -9.3% | — | Bottom 12% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -6.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 6.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -18.7 pp
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 1.13%
- Shareholder yield
- 1.13%
- Share count change, 1 year
- +0.4%
- Share count change, 3-year CAGR
- +1.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +21.8%
- Average 2-day reaction, last 8
- +0.8%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $6.00
- Target vs current price
- +460.7%
- Analysts with a rating
- 6
- Share rating Buy or Strong Buy
- 67%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 12, 2026 | +11.1% | +2.4% | +2.4% | -1.6% | — |
| May 12, 2026 | +60.0% | +0.6% | +29.8% | +45.7% | +35.9% |
| Mar 24, 2026 | +25.0% | -2.2% | -10.7% | +15.0% | +49.3% |
| Nov 12, 2025 | -9.1% | +1.9% | +10.3% | -0.6% | -48.9% |
| Aug 6, 2025 | -20.0% | -1.0% | -38.3% | -33.0% | -26.7% |
| May 7, 2025 | +0.0% | +3.0% | -17.3% | -10.2% | -23.3% |
| Mar 11, 2025 | +16.7% | +1.5% | -4.7% | -27.8% | -30.1% |
| Nov 6, 2024 | +15.4% | +0.5% | -8.3% | -4.9% | +16.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.08 | -$0.09 | +11.1% | $7.3M |
| May 12, 2026 | -$0.04 | -$0.10 | +60.0% | $9.7M |
| Mar 24, 2026 | -$0.06 | -$0.08 | +25.0% | $7.3M |
| Nov 12, 2025 | -$0.12 | -$0.11 | -9.1% | $6.8M |
| Aug 6, 2025 | -$0.12 | -$0.10 | -20.0% | $8.5M |
| May 7, 2025 | -$0.10 | -$0.10 | +0.0% | $10.4M |
| Mar 11, 2025 | -$0.10 | -$0.12 | +16.7% | $8.7M |
| Nov 6, 2024 | -$0.11 | -$0.13 | +15.4% | $8.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 3.76× | — | — | Top 46% |
| Free-cash-flow yield | -20.76% | — | — | Bottom 24% |
| Earnings yield | -31.24% | — | — | Bottom 23% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -2.7%
- 200-day average slope (20 days)
- -3.8%
- Distance from 50-day average
- -11.2%
- Distance from 200-day average
- -1.1%
- RSI (14)
- 33.5
- Relative volume
- 0.63×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 60.2%
- Volatility vs own 5-year history
- 29th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.12
- Correlation with S&P 500
- 0.27
- Current drawdown from 1-year high
- -41.5%
- Maximum drawdown, 3 years
- -87.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 3, 2021 | Mar 30, 2026 | -96.1% | 1145 days | Not yet recovered |
| Jul 30, 2021 | Aug 25, 2021 | -19.7% | 18 days | 7 days (Sep 3, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $114.6M
- EPS, diluted (TTM)
- -$0.33
- Revenue (TTM)
- $31.1M
- 52-week range
- $0.64 – $1.87
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $33.9M | $44.3M | $41.3M | $38.6M | $33.0M |
| Gross profit | $30.2M | $39.2M | $36.5M | $31.5M | $26.8M |
| Operating income | -$18.2M | -$27.4M | -$48.3M | -$51.2M | -$45.3M |
| Net income | -$19.1M | -$23.6M | -$37.9M | -$41.1M | -$44.6M |
| EPS (diluted) | -$0.22 | -$0.19 | -$0.37 | -$0.39 | -$0.42 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2M | $8.7M | $10.4M | $8.5M | $6.8M | $7.3M | $9.7M | $7.3M |
| Net income | -$11.6M | -$10.6M | -$10.3M | -$12.4M | -$12.4M | -$9.6M | -$4.8M | -$8.9M |
| EPS (diluted) | -$0.11 | -$0.10 | -$0.10 | -$0.12 | -$0.12 | -$0.09 | -$0.04 | -$0.08 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$10.7M | -$14.8M | -$21.7M | -$27.6M | -$34.4M |
| Capital expenditure | -$3.8M | -$18.5M | -$3.7M | -$1.7M | -$1.8M |
| Free cash flow | -$14.5M | -$33.3M | -$25.4M | -$29.3M | -$36.2M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $236.1M | $2.9M | $269,000 | $2.1M | $656,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $105.7M
- Total assets
- $184.7M
- Total liabilities
- $25.9M
- Total debt
- $17.3M
- Net debt
- $2.2M
- Shareholders’ equity
- $158.8M
As of Jun 30, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 1,170,407
- Days to cover
- 2.81
- Change vs previous report
- -10.1%
FINRA short interest, settlement date Sep 15, 2026.